Monographie - Deferoxamine mesylate

Ultimele actualizari :
19/11/2024

Deferoxamine mesylate

Formula chimica

Denumirea comerciala

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Deferoxamina	Spania
Deferoxamine mesylate	Canada, SUA
Deferoxaminmesilat	Germania
Desferal	Arabia Saudita, Argentina, Australia, Austria, Belgia, Canada, Chilli, Columbia, Danemarca, Egipt, Elvetia, Finlanda, Franta, Germania, Grecia, India, Iran, Irlanda, Islanda, Italia, Luxemburg, Malaezia, Marea Britanie, Maroc, Mexic, Norvegia, Olanda, Polonia, Portugalia, Romania, SUA, Suedia, Tunisia, Turcia, Ungaria, Venezuela
Desferin	Danemarca, Spania
Desferioxamine mesilate	Marea Britanie
Desfonak	Iran
PMS desferoxamine	Canada
Talifer	Mexic

Bibliografie : Deferoxamine mesylate

	tip	publicare
5	ziar	Stiles ML, Allen LV Jr, Prince SJ. Stability of deferoxamine mesylate, floxuridine, fluorouracil, hydromorphone hydrochloride, lorazepam, and midazolam hydrochloride in polypropylene infusion-pump syringes. Am J Health-Syst Pharm 1996 ; 53: 1583-1588.
604	Laborator	Stabilité des médicaments dans l'Intermate® SV50, 100, 200 Baxter 1998
960	ziar	Koren G, Tesoro A, Leeder JS, Bentur Y, Olivieri N. Stability of aqueous solutions of deferoxamine. Can J Hosp Pharm 1990 ; 43: 57-60.
1669	ziar	Hayes DM, Reilly RM, Lee MMC. The pharmaceutical stability of deferoxamine mesylate. Can J Hosp Pharm 1994 ; 47: 9-14.
2156	ziar	Kane MP, Bailie GR, Moon DG, Siu I. Stability of deferoxamine peritoneal dialysate solutions. Perit Dial Int 1994 ; 14: 396-398.
3671	Laborator	Deferoxamine - Résumé des caractéristiques du produit Teva UK Ltd 2016
3728	ziar	Correard F, Savry A, Gauthier-Villano L, Pisano P, Pourroy B. Visual compatibility of defibrotide with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2014 ; 71: 1288-1291.

Mentions Légales